|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 126, Issue 19 4247-4255, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
U Borello, M Coletta, S Tajbakhsh, L Leyns, EM De Robertis, M Buckingham and G Cossu
Istituto Pasteur-Cenci Bolognetti, Dipartimento di Istologia ed Embriologia Medica, Universita di Roma 'La Sapienza', Via A. Scarpa 14, Italy.
Axial structures (neural tube/notochord) and surface ectoderm activate myogenesis in the mouse embryo; their action can be reproduced, at least in part, by several molecules such as Sonic hedgehog and Wnts. Recently, soluble Wnt antagonists have been identified. Among those examined only Frzb1 was found to be expressed in the presomitic mesoderm and newly formed somites and thus its possible role in regulating myogenesis was investigated in detail. When presomitic mesoderm or newly formed somites were cultured with axial structures and surface ectoderm on a feeder layer of C3H10T1/2 cells expressing Frzb1, myogenesis was abolished or severely reduced in presomitic mesoderm and the three most recently formed somites. In contrast, no effect was observed on more mature somites. Inhibition of myogenesis did not appear to be associated with increased cell death since the final number of cells in the explants grown in the presence of Frzb1 was only slightly reduced in comparison with controls. In order to examine the possible function of Frzb1 in vivo, we developed a method based on the overexpression of the soluble antagonist by transient transfection of WOP cells with a Frzb1 expression vector and injection of transfected cells into the placenta of pregnant females before the onset of maternofoetal circulation. Frzb1, secreted by WOP cells, accumulated in the embryo and caused a marked reduction in size of caudal structures. Myogenesis was strongly reduced and, in the most severe cases, abolished. This was not due to a generalized toxic effect since only several genes downstream of the Wnt signaling pathway such as En1, Noggin and Myf5 were downregulated; in contrast, Pax3 and Mox1 expression levels were not affected even in embryos exhibiting the most severe phenotypes. Taken together, these results suggest that Wnt signals may act by regulating both myogenic commitment and expansion of committed cells in the mouse mesoderm.
This article has been cited by other articles:
|
|
 |
|
  C.-H. Kim, H. Neiswender, E. J. Baik, W. C. Xiong, and L. Mei {beta}-Catenin Interacts with MyoD and Regulates Its Transcription Activity Mol. Cell. Biol., May 1, 2008; 28(9): 2941 - 2951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Borello, B. Berarducci, P. Murphy, L. Bajard, V. Buffa, S. Piccolo, M. Buckingham, and G. Cossu The Wnt/{beta}-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis Development, September 15, 2006; 133(18): 3723 - 3732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Vertino, J. M. Taylor-Jones, K. A. Longo, E. D. Bearden, T. F. Lane, R. E. McGehee Jr., O. A. MacDougald, and C. A. Peterson Wnt10b Deficiency Promotes Coexpression of Myogenic and Adipogenic Programs in Myoblasts Mol. Biol. Cell, April 1, 2005; 16(4): 2039 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Song, W. Shi, Y.-Y. Xiang, and J. Filmus The Loss of Glypican-3 Induces Alterations in Wnt Signaling J. Biol. Chem., January 21, 2005; 280(3): 2116 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tagliafico, S. Brunelli, A. Bergamaschi, L. De Angelis, R. Scardigli, D. Galli, R. Battini, P. Bianco, S. Ferrari, G. Cossu, et al. TGF{beta}/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts J. Cell Sci., September 1, 2004; 117(19): 4377 - 4388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Anakwe, L. Robson, J. Hadley, P. Buxton, V. Church, S. Allen, C. Hartmann, B. Harfe, T. Nohno, A. M. C. Brown, et al. Wnt signalling regulates myogenic differentiation in the developing avian wing Development, August 1, 2003; 130(15): 3503 - 3514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Esteve, F. Trousse, J. Rodriguez, and P. Bovolenta SFRP1 modulates retina cell differentiation through a {beta}-catenin-independent mechanism J. Cell Sci., June 15, 2003; 116(12): 2471 - 2481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Murdoch, K. Chadwick, M. Martin, F. Shojaei, K. V. Shah, L. Gallacher, R. T. Moon, and M. Bhatia Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells invivo PNAS, March 18, 2003; 100(6): 3422 - 3427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mukhopadhyay, A. Teufel, T. Yamashita, A. D. Agulnick, L. Chen, K. M. Downs, A. Schindler, A. Grinberg, S.-P. Huang, D. Dorward, et al. Functional ablation of the mouse Ldb1 gene results in severe patterning defects during gastrulation Development, February 1, 2003; 130(3): 495 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Petropoulos and I. S. Skerjanc beta -Catenin Is Essential and Sufficient for Skeletal Myogenesis in P19 Cells J. Biol. Chem., May 3, 2002; 277(18): 15393 - 15399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Nervi, U. Borello, F. Fazi, V. Buffa, P. G. Pelicci, and G. Cossu Inhibition of Histone Deacetylase Activity by Trichostatin A Modulates Gene Expression during Mouse Embryogenesis without Apparent Toxicity Cancer Res., February 1, 2001; 61(4): 1247 - 1249. [Abstract] [Full Text]
|
|
|
|
|
|
A. Borycki, A. M. Brown, and C. P. Emerson Shh and Wnt signaling pathways converge to control Gli gene activation in avian somites Development, May 15, 2000; 127(10): 2075 - 2087. [Abstract] [PDF]
|
|
|
|
|
|
M Schmidt, M Tanaka, and A Munsterberg Expression of (beta)-catenin in the developing chick myotome is regulated by myogenic signals Development, January 10, 2000; 127(19): 4105 - 4113. [Abstract] [PDF]
|
|
|
|
|
|
C. Lee, L. Buttitta, N. May, A Kispert, and C. Fan SHH-N upregulates Sfrp2 to mediate its competitive interaction with WNT1 and WNT4 in the somitic mesoderm Development, January 1, 2000; 127(1): 109 - 118. [Abstract] [PDF]
|
|
